Lithuania

Almost every summary of European GLP-1 logistics, including the ABDA factsheet this site cites elsewhere, works from a list of seven EU member states that permit prescription mail order. Lithuania is not on that list. Lithuania belongs on it.

Ministry of Health order V-1491, effective 12 July 2022, established the regime for remote retail trade in medicinal products including prescription medicines. The VVKT, the State Medicines Control Agency, operates a public register of pharmacies authorised for remote trade, which listed nineteen authorised remote pharmacies at the point this page was written. Authorised pharmacies must display the EU common logo, verify the prescription through the national e-prescription system and meet delivery and cold-chain conditions.

This site does not resolve the discrepancy with the ABDA list; it records it. The primary Lithuanian instrument and the operating register are the stronger evidence, and the ABDA factsheet is most likely working from an older enumeration. Anyone relying on the seven-state figure for a logistics plan should check it against the national registers directly.

A second widely repeated claim is that Lithuania restricted pharmacy ownership in 2023, citing the 34 pharmacies that closed on 1 July 2023. That is a misreading.

The reform required a qualified pharmacist to be physically present during opening hours at each pharmacy, ending the arrangement under which one pharmacist supervised several outlets remotely or intermittently. The closures were a staffing consequence, concentrated in small rural outlets that could not recruit a resident pharmacist, and they were widely reported as an access problem.

There is no pharmacist-ownership requirement in the Lithuanian pharmacy regime. A legal entity may hold a pharmacy licence provided the professional staffing conditions are met. That places Lithuania in the open-ownership group alongside Czechia, Slovakia, Poland and Portugal.

Open ownership plus lawful prescription mail order plus mature e-prescribing is a rare combination in the EU, and only the Netherlands and a handful of others match it. Lithuania is the cheapest place in that group to hold the licence.

The limit is reach. A Lithuanian remote pharmacy may dispense to Lithuanian patients under Lithuanian rules; it does not thereby acquire the right to ship into Germany, France or anywhere else, because the destination country’s dispensing rules govern the delivery. The Dutch route is used for cross-border volume because of the specific combination of Dutch tolerance policy and destination-state permissiveness, not because a mail-order licence travels.

So the honest reading is: Lithuania is a good place to run a small compliant domestic mail-order pharmacy and a good place to learn the operating model cheaply. It is not a base from which to serve Europe.

Dokteronline appears in Lithuanian-language search results and is often assumed to be operating locally. It does not appear on the VVKT register of pharmacies authorised for remote trade in medicinal products.

That matters in both directions. For a patient it means the supply is not under Lithuanian pharmacy supervision. For an operator it is a reminder that visibility in a market and authorisation in a market are unrelated, and that the register, not the search results, is the source of truth.